Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
Children's Oncology Group
Children's Oncology Group
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Thomas Jefferson University
City of Hope Medical Center
The University of Texas Health Science Center, Houston
Universitätsklinikum Hamburg-Eppendorf
Milton S. Hershey Medical Center
Arog Pharmaceuticals, Inc.
Queen Mary University of London
Masonic Cancer Center, University of Minnesota
University of Nebraska
University of Nebraska
Arog Pharmaceuticals, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Thomas Jefferson University
University of Nebraska
University of Nebraska
Children's Oncology Group
Children's Hospital Los Angeles
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Goethe University
Children's Oncology Group
Therapeutic Advances in Childhood Leukemia Consortium
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Alliance for Clinical Trials in Oncology
Children's Oncology Group
Children's Oncology Group
Weill Medical College of Cornell University
Bristol-Myers Squibb
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Children's Oncology Group
Stanford University
Children's Oncology Group
Washington University School of Medicine
St. Jude Children's Research Hospital
Stanford University
University of Arkansas
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
OHSU Knight Cancer Institute
Washington University School of Medicine
Newcastle-upon-Tyne Hospitals NHS Trust
Washington University School of Medicine
St. Jude Children's Research Hospital